The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
高端彩妆品牌Charlotte Tilbury以持续强劲的两位数贡献，推动PUIG彩妆板块全年业绩增长10.7%至8.45亿欧元。拜尔斯道夫旗下高端护肤品牌莱珀妮销售额却同比下滑4.5%至4.78亿欧元，并连续3年负增长。
。关于这个话题，雷电模拟器官方版本下载提供了深入分析
«Политически и иначе». МИД Ирана рассказал о помощи России и Китая на фоне ударов Запада02:24
// Some TLS servers fail if the record version is
Зеленский заявил о запросе от США на участие Киева в ситуации на Ближнем Востоке20:47